Association of immunohistochemical detection of urokinase-type plasminogen activator with metastasis and prognosis in colorectal cancer - PubMed (original) (raw)
. 1995 Jul-Aug;52(4):347-52.
doi: 10.1159/000227487.
Affiliations
- PMID: 7777251
- DOI: 10.1159/000227487
Association of immunohistochemical detection of urokinase-type plasminogen activator with metastasis and prognosis in colorectal cancer
T Sato et al. Oncology. 1995 Jul-Aug.
Abstract
We evaluated urokinase-type plasminogen activator (uPA) expression with immunohistochemistry in 90 cases of colorectal cancer and compared it with the clinicopathological findings. Patients who had cancer cells which were stained intensively relative to the background were recognized as uPA-positive patients. The uPA-positive rate was 36.7% (33/90) in total cases. There was a significant correlation was also seen between uPA expression and liver metastasis. Prognosis was poorer in the uPA-positive patients than in the uPA-negative patients. Therefore, uPA may be a good predictor of metastasis and prognosis.
Similar articles
- Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 as a prognostic factor in human colorectal carcinomas.
Fujii T, Obara T, Tanno S, Ura H, Kohgo Y. Fujii T, et al. Hepatogastroenterology. 1999 Jul-Aug;46(28):2299-308. Hepatogastroenterology. 1999. PMID: 10521987 - Urokinase receptor and vascular endothelial growth factor are synergistically associated with the liver metastasis of colorectal cancer.
Konno H, Abe J, Kaneko T, Baba M, Shoji A, Sunayama K, Kamiya K, Tanaka T, Suzuki S, Nakamura S, Urano T. Konno H, et al. Jpn J Cancer Res. 2001 May;92(5):516-23. doi: 10.1111/j.1349-7006.2001.tb01124.x. Jpn J Cancer Res. 2001. PMID: 11376560 Free PMC article. - Fibrinolysis components as prognostic markers in breast cancer and colorectal carcinoma.
Gandolfo GM, Conti L, Vercillo M. Gandolfo GM, et al. Anticancer Res. 1996 Jul-Aug;16(4B):2155-9. Anticancer Res. 1996. PMID: 8694536 Review. - [The role of cathepsins and the plasminogen activator/inhibitor system in colorectal cancer].
Herszényi L, Farinati F, Plebani M, István G, Sápi Z, Carraro P, De Paoli M, Naccarato R, Tulassay Z. Herszényi L, et al. Orv Hetil. 1999 Aug 15;140(33):1833-6. Orv Hetil. 1999. PMID: 10489782 Review. Hungarian.
Cited by
- Tumor Budding, uPA, and PAI-1 in Colorectal Cancer: Update of a Prospective Study.
Märkl B, Hardt J, Franz S, Schaller T, Schenkirsch G, Kriening B, Hoffmann R, Rüth S. Märkl B, et al. Gastroenterol Res Pract. 2017;2017:6504960. doi: 10.1155/2017/6504960. Epub 2017 Feb 12. Gastroenterol Res Pract. 2017. PMID: 28286517 Free PMC article. - Prognostic and Predictive Significance of Stromal Fibroblasts and Macrophages in Colon Cancer.
Owusu BY, Vaid M, Kaler P, Klampfer L. Owusu BY, et al. Biomark Cancer. 2015 Nov 2;7(Suppl 1):29-37. doi: 10.4137/BIC.S25247. eCollection 2015. Biomark Cancer. 2015. PMID: 26568685 Free PMC article. Review. - High tPA-expression in primary melanoma of the limb correlates with good prognosis.
Ferrier CM, Suciu S, van Geloof WL, Straatman H, Eggermont AM, Koops HS, Kroon BB, Lejeune FJ, Kleeberg UR, van Muijen GN, Ruiter DJ. Ferrier CM, et al. Br J Cancer. 2000 Nov;83(10):1351-9. doi: 10.1054/bjoc.2000.1460. Br J Cancer. 2000. PMID: 11044361 Free PMC article. - Protein markers in colorectal cancer: predictors of liver metastasis.
Berney CR, Fisher RJ, Yang J, Russell PJ, Crowe PJ. Berney CR, et al. Ann Surg. 1999 Aug;230(2):179-84. doi: 10.1097/00000658-199908000-00007. Ann Surg. 1999. PMID: 10450731 Free PMC article. - Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.
Ganesh S, Sier CF, Heerding MM, van Krieken JH, Griffioen G, Welvaart K, van de Velde CJ, Verheijen JH, Lamers CB, Verspaget HW. Ganesh S, et al. Br J Cancer. 1997;75(12):1793-801. doi: 10.1038/bjc.1997.306. Br J Cancer. 1997. PMID: 9192984 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous